Farida Dakterzada Sedaghat
Grado: Doctor/a
973702413
fdakterzada(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/G-4155-2016
Publicaciones
-
Dakterzada F; David Benítez I; Targa A; Lladó A; Torres G; Romero L; de Gonzalo-Calvo D; Moncusí-Moix A; Tort-Merino A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer's Disease.
FRONTIERS IN AGING NEUROSCIENCE 13 705989-705989. .
-
Jorge C; Cetó M; Arias A; Blasco E; Gil MP; López R; Dakterzada F; Purroy F; Piñol-Ripoll G
Level of understanding of Alzheimer disease among caregivers and the general population.
Neurologia (barcelona, Spain) 36 426-432. .
-
Dakterzada F; López-Ortega R; Arias A; Riba-Llena I; Ruiz-Julián M; Huerto R; Tahan N; Piñol-Ripoll G
Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest.
FRONTIERS IN AGING NEUROSCIENCE 13 604119-604119. .
-
Targa A; Dakterzada F; Benítez I; López R; Pujol M; Dalmases M; Arias A; Sánchez-de-la-Torre M; Zettenberg H; Blennow K; Pamplona R; Jové M; Barbé F; Piñol-Ripoll G
Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in Alzheimer's disease patients.
Sleep 44 -. .
-
Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
Alzheimers Research & Therapy 12 163-163. .
-
Torres-Bondia F; Dakterzada F; Galván L; Buti M; Besanson G; Gill E; Buil R; de Batlle J; Piñol-Ripoll G
Proton pump inhibitors and the risk of Alzheimer's disease and non-Alzheimer's dementias.
SCIENTIFIC REPORTS 10 21046-21046. .
-
Jorge C; Targa A; Benítez ID; Dakterzada F; Torres G; Minguez O; Carnes A; Pujol M; Gibert A; López R; Gaeta AM; Dalmases M; Farré R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Obstructive sleep apnoea and cognitive decline in mild-to-moderate Alzheimer's disease.
EUROPEAN RESPIRATORY JOURNAL 56 -. .
-
Targa, A; Dakterzada, F; Benitez, ID; de Gonzalo-Calvo, D; Moncusi-Moix, A; Lopez, R; Pujol, M; Arias, A; de Batlle, J; Sanchez-de-la-Torre, M; Barbe, F; Piñol-Ripoll G
Circulating MicroRNA Profile Associated with Obstructive Sleep Apnea in Alzheimer's Disease.
MOLECULAR NEUROBIOLOGY 57 4363-4372. .
-
Lara, B; Carnes, A; Dakterzada, F; Benitez, I; Piñol-Ripoll G
Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer's disease during the COVID-19 lockdown.
EUROPEAN JOURNAL OF NEUROLOGY 27 1744-1747. .
-
Pinol-Ripoll, G; Targa, A; Benitez, I; Dakterzada, F; Lopez, R; Barbe, F
Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in Alzheimer's disease patients
JOURNAL OF SLEEP RESEARCH 29 21-21. .
-
Pinol-Ripoll, G; Targa, A; Dakterzada, F; Benitez, I; Carnes, A; Barbe, F
Obstructive sleep apnea and evolution of Alzheimer's disease patients
JOURNAL OF SLEEP RESEARCH 29 102-102. .
-
Gaeta, AM; Benítez ID; Jorge, C; Torres, G; Dakterzada, F; Minguez, O; Huerto, R; Pujol, M; Carnes, A; Dalmases, M; Gibert, A; Farr?, R; de la Torres, MS; Barb?, F; Pi?ol-Ripoll, G
Prevalence of obstructive sleep apnea in Alzheimer's disease patients
JOURNAL OF NEUROLOGY 267 1012-1022. .
Proyectos
- Insight into the role of lipids in frontotemporal dementia: uncovering pathophysiological alterations and biomarker discovery opportunities.
- Development of dynamic models for the personalized prevention and treatment of age-related diseases
- Importancia del sueño y los ritmos circadianos en la biología y evolución clínica de los sujetos en el continuum de la Enfermedad de Alzheimer.
- Ajuts per a la contractació de personal investigador novell (FI-2019)
- Biomarcadores lipidómicos de la progresión de la enfermedad de Alzheimer en pacientes con deterioro cognitivo leve
- Programes de recerca: estudi de biomarcadors i desenvolupament de noves estratègies terapèutiques en una cohort multicèntrica de Demència Frontotemporal